Nutex Health Inc.
NUTX
$122.02
-$1.38-1.12%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 263.83% | 213.96% | -42.23% | 91.30% | 90.92% |
| Total Depreciation and Amortization | 11.77% | 7.85% | 13.56% | 15.11% | 20.75% |
| Total Amortization of Deferred Charges | -40.66% | -13.84% | -76.20% | -71.24% | -19.97% |
| Total Other Non-Cash Items | 337.50% | 85.47% | 1,216.64% | -91.07% | -92.91% |
| Change in Net Operating Assets | -4,742.56% | -6,190.25% | -109.64% | -96.13% | -104.86% |
| Cash from Operations | 2,083.08% | 1,742.88% | 182.87% | 1,053.05% | -79.55% |
| Capital Expenditure | 72.07% | 75.74% | 55.67% | 38.78% | 43.82% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | 105.36% | -- | -105.54% |
| Divestitures | -- | 65.23% | 65.23% | 31.55% | 100.00% |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 69.56% | 76.29% | 66.77% | 26.79% | -464.45% |
| Total Debt Issued | -46.80% | -61.67% | 11.56% | -30.47% | 186.89% |
| Total Debt Repaid | 41.73% | 22.63% | 0.49% | -23.23% | -163.61% |
| Issuance of Common Stock | -41.71% | 2,198.25% | 1,587.96% | 1,177.58% | 70.91% |
| Repurchase of Common Stock | -- | -- | -12.84% | -12.84% | -12.84% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -351.72% | 82.09% | 82.09% | 82.09% | 90.13% |
| Other Financing Activities | -23.46% | -23.46% | 27.78% | 78.22% | 70.10% |
| Cash from Financing | -2,523.13% | 148.02% | 101.24% | 44.19% | 102.69% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 2,137.24% | 276.11% | 305.05% | 154.24% | -3.99% |